Metoprolol Tartrate

酒石酸美托洛尔

Report date: 2026/01/27 20:00:10
NME

Base Information

Drug NameMetoprolol Tartrate
Drug Alias Name美多心Metoprolol美多心安Metoprololum美托洛尔酒石酸盐 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsNeurocirculatory AstheniaHyperthyroidismEssential Hypertension +[15] 
Global Approved IndicationsNeurocirculatory AstheniaHyperthyroidismEssential Hypertension +[11] 
Approved Indications in ChinaNeurocirculatory AstheniaHyperthyroidismHypertension +[9] 
Original Approved Country/TerritoryUnited States
Original Approved Date1978/08/07
Country/TerritoryUnited StatesEgyptSpain +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUs Pharm Holdings
China Registration ClassN/A

Develop Information

Active CompaniesValidus PharmaceuticalsAstrazeneca Pharmaceutical Co LtdThe University Of Chicago +[6] 
Inactive CompaniesMylan Pharmaceuticals Inc
Active IndicationsNeurocirculatory AstheniaHyperthyroidismEssential Hypertension +[15] 
Inactive IndicationsN/A

Other Information

ATC CodeC07AB02
Related LinksWikipediaDrugBankKEGG